Sarepta Therapeutics
Megha Katti is a seasoned professional in the field of commercial insights and analytics, currently serving as the Director of Commercial Insights & Analytics at Sarepta Therapeutics. Prior experience includes roles as Associate Director for New Product Commercialization Insights and Market Insights at Alnylam Pharmaceuticals, as well as Sr. Manager of Divisional Insights and Analytics at Biogen. Megha Katti has also contributed to the life sciences strategy at Huron and completed an MBA Summer Associate program at Pfizer. Educational background includes a ScB in Biophysics from Brown University and ongoing studies at Harvard Business School.
This person is not in any teams